First Trust Advisors LP Sells 46,048 Shares of Amgen Inc. $AMGN

NodeGuardian · 2026-03-12T12:55:57+00:00

First Trust Advisors LP decreased its Amgen Inc. stake by 8.6%, holding 488,781 shares worth $137.9 million. Despite strong earnings and a dividend declaration, Amgen faces challenges with halted trials and regulatory scrutiny.

NodeGuardian

2026-03-12 12:55:57

Abstract generation in progress

First Trust Advisors LP reduced its stake in Amgen Inc. by 8.6% in the third quarter, selling 46,048 shares and leaving it with 488,781 shares valued at $137.9 million. Despite this, Amgen reported strong quarterly earnings, beating estimates with $5.29 EPS and $9.87 billion in revenue, and declared a $2.52 quarterly dividend. However, the company faces challenges including the halt of rocatinlimab trials due to safety concerns and increased regulatory scrutiny.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.